Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × pomalidomide × Clear all

NCT00072722 2006-12-19

Safety and Efficacy of CC-4047 in Subjects With Metastatic Hormone Refractory Prostate Cancer (HRPC)

Phase 2 Completed

Prostatic Neoplasms